• Kehinde Alare, Elishama Abioye, and Biam Saydo.
• Department of Medicine, Ladoke Akintola University of Technology, Ogbomoso, Nigeria. Kehinde.alare@physicianscientists.org.
• Neurocrit Care. 2024 Jun 24.

AbstractGerstmann syndrome, characterized by a tetrad of symptoms, which are agraphia, acalculia, left-right disorientation, and finger agnosia, presents challenges in both understanding its pathophysiology and establishing effective treatment modalities. Neuroanatomical studies have highlighted the involvement of the dominant parietal lobe, particularly the inferior parietal lobule, in the development of Gerstmann syndrome. Although current treatment options are largely supportive, recent research suggests a potential role for deep brain stimulation (DBS) in managing this condition. DBS, known for its efficacy in various neurological disorders, has been hypothesized to modulate neuronal pathways associated with Gerstmann syndrome. However, clinical evidence supporting DBS in Gerstmann syndrome remains scarce, posing challenges in patient selection and ethical considerations. Future research should prioritize investigating the efficacy and safety of DBS in Gerstmann syndrome to improve patient outcomes and quality of life.© 2024. Springer Science+Business Media, LLC, part of Springer Nature and Neurocritical Care Society.

4 keywords...

hide…